Feed 207940.KS
20

Samsung Biologics Co.,Ltd. 207940.KS KSC · Healthcare · South Korea

₩1,349,000.00 -1.24% -₩17,000.00

Market cap
₩63.6T
Enterprise value
₩64.5T
P/E
35.3x
Forward P/E
35.1x
PEG
0.6x
P/S
14.5x
P/FCF
39.6x
EV/EBITDA
25.5x
ROIC
13.9%
Gross margin
68.6%
Net margin
41.1%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
0.4x
Beta
0.19
Free float
25.4%

Sector

Healthcare

Industry

Biotechnology

CEO

John Chongbo Rim

Employees

5,455

Headquarters

Incheon

Valuation

Is today's price reasonable?

  • What to watch: You pay 35.3 KRW for 1 KRW of yearly profit, a lot for its sector.

Growth and estimates

Is it growing, and what comes next?

  • What speaks for it: Earnings per share grew by 30% a year over the last 3 years.
  • What speaks for it: Analysts expect revenue to grow by 22% this fiscal year.
  • What to watch: It missed profit estimates 5 times in the last 8 quarters.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What speaks for it: Out of every 100 KRW of revenue, 41 KRW is left as net profit.
  • What speaks for it: It earns 14 KRW a year on every 100 KRW of invested capital.

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy